Unknown

Dataset Information

0

Mechanistic insights into the protective roles of polyphosphate against amyloid cytotoxicity.


ABSTRACT: The universally abundant polyphosphate (polyP) accelerates fibril formation of disease-related amyloids and protects against amyloid cytotoxicity. To gain insights into the mechanism(s) by which polyP exerts these effects, we focused on ?-synuclein, a well-studied amyloid protein, which constitutes the major component of Lewy bodies found in Parkinson's disease. Here, we demonstrate that polyP is unable to accelerate the rate-limiting step of ?-synuclein fibril formation but effectively nucleates fibril assembly once ?-synuclein oligomers are formed. Binding of polyP to ?-synuclein either during fibril formation or upon fibril maturation substantially alters fibril morphology and effectively reduces the ability of ?-synuclein fibrils to interact with cell membranes. The effect of polyP appears to be ?-synuclein fibril specific and successfully prevents the uptake of fibrils into neuronal cells. These results suggest that altering the polyP levels in the extracellular space might be a potential therapeutic strategy to prevent the spreading of the disease.

SUBMITTER: Lempart J 

PROVIDER: S-EPMC6751573 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mechanistic insights into the protective roles of polyphosphate against amyloid cytotoxicity.

Lempart Justine J   Tse Eric E   Lauer James A JA   Ivanova Magdalena I MI   Sutter Alexandra A   Yoo Nicholas N   Huettemann Philipp P   Southworth Daniel D   Jakob Ursula U  

Life science alliance 20190918 5


The universally abundant polyphosphate (polyP) accelerates fibril formation of disease-related amyloids and protects against amyloid cytotoxicity. To gain insights into the mechanism(s) by which polyP exerts these effects, we focused on α-synuclein, a well-studied amyloid protein, which constitutes the major component of Lewy bodies found in Parkinson's disease. Here, we demonstrate that polyP is unable to accelerate the rate-limiting step of α-synuclein fibril formation but effectively nucleate  ...[more]

Similar Datasets

| S-EPMC7037038 | biostudies-literature
| S-EPMC5952579 | biostudies-literature
| S-EPMC8637561 | biostudies-literature
| S-EPMC6085999 | biostudies-literature
| S-EPMC4268158 | biostudies-literature
| S-EPMC4785718 | biostudies-literature
| S-EPMC8000266 | biostudies-literature
| S-EPMC4645622 | biostudies-literature
2024-09-04 | GSE266471 | GEO
| S-EPMC3049775 | biostudies-literature